Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ZYME stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ZYME investment potential.

What is ZYME stock price today?

Get real-time ZYME stock price, historical data, and price charts on Financhill. Track ZYME performance with our advanced analysis tools.

Is ZYME a good investment?

Evaluate ZYME investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ZYME stock?

To buy ZYME stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ZYME?

View detailed market capitalization data and company valuation metrics for ZYME on our comprehensive analysis page.

What is the P/E ratio of ZYME?

Use our fundamental analysis tools to view ZYME P/E ratio and compare valuation metrics with industry peers.

What are ZYME earnings?

View ZYME earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Zymeworks, Inc. Stock Predictions

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Buy

ZYME
Zymeworks, Inc.

Last Price:

$23.63

Seasonality Move:

-13.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Exxon and Chevron Have an Unlikely New Competitor

Zymeworks, Inc. Stock Forecast

Over the next 52 weeks, Zymeworks, Inc. has on average historically risen by 40.4% based on the past 8 years of stock performance.
Zymeworks, Inc. has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Is Zymeworks, Inc. Stock Undervalued?

The current Zymeworks, Inc. [ZYME] share price is $24.62. The Score for ZYME is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
ZYME is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Zymeworks, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Zymeworks, Inc. has on average historically risen by 40.4% based on the past 8 years of stock performance.

Zymeworks, Inc. Stock Rating

Buy

Zymeworks, Inc. (ZYME) is a Buy

Is Zymeworks, Inc. overpriced?

Zymeworks, Inc. has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Zymeworks, Inc. Stock Price History

Is ZYME stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZYME is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

zymeworks.com

52-Week Data

52-Week High:

28.49

52-Week Low:

9.03

Prediction Charts

Market Cap:

1.9B

Price in USD:

24.62

Volume:

981.1K

Beta:

1.16

Technical Analysis

SMA50:

24.06

SMA100:

20.36

SMA200:

16.41

52-Wk Change:

80.76%

Stock Predictions

Is Zymeworks, Inc. stock public?

Yes, Zymeworks, Inc. is a publicly traded company.
What is the Zymeworks, Inc. stock quote today?

The Zymeworks, Inc. stock price is 24.62 USD today.
How to buy Zymeworks, Inc. stock online?

You can buy Zymeworks, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-24	27.11	26.86	27.28	26.74
Dec-26	26.87	26.87	26.98	26.51
Dec-29	26.66	26.74	26.86	26.19
Dec-30	26.48	26.54	26.91	26.10
Dec-31	26.43	26.33	26.88	26.15
Jan-2	26.12	26.62	26.84	25.68
Jan-5	26.59	25.48	27.13	24.59
Jan-6	25.32	24.18	25.32	23.71
Jan-7	24.09	24.85	25.35	24.04
Jan-8	24.54	23.10	24.95	22.94
Jan-9	23.46	23.17	23.81	22.80
Jan-12	23.01	23.16	23.43	22.46
Jan-13	23.35	23.92	24.35	23.23
Jan-14	23.71	24.62	24.67	23.15

Zymeworks, Inc. Earnings

Zymeworks, Inc. Earnings Report: Per Share Zymeworks, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Zymeworks, Inc. Forecast Revenue Growth

Zymeworks, Inc. Stock Analysis: Historical quarterly revenues per share for Zymeworks, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.15 per share, and a decrease next year of $0.20 per share.

* Zymeworks, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.